Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>Events>This Event
  Events - September 2013


SMi - Geriatric Safe Medicines Summit

16 Sep 2013 - 17 Sep 2013 - London, UK



Bookmark and Share


Clinical research in geriatric patient populations requires the adaptation of traditional clinical procedures in research studies. A relatively new area of research, geriatric patient studies requires a collaboration between many different stakeholders within this field to identify and overcome the challenges involved in recruiting, treating and retaining study subjects. Join SMi as we look to address these issues with new and innovative thinking and approaches that are being applied to geriatric clinical studies.

KEY REASONS TO ATTEND

Discover the benefits of performing clinical trials in older people

Identify the key challenges and considerations when conducting clinical trials in older people

Address reasons for clinical trial retention difficulties

Discuss how modelling and simulation along with new patient reporting systems support clinical trials in older people

Explore new market gaps and discover new market strategy

Focus on the EMA geriatric medicines strategy

KEYNOTE SPEAKERS INCLUDE:

Solange Rohou, Director of Regulatory Affairs, AstraZeneca

Barbro Westerholm, Member of Parliament, Sweden, Liberal Party

Florian Von Raison, Global Programme Head, Novartis

Nina Barnett, Consultant Pharmacologist, Northwest London's Hospital NHS Trust

Philippe Guillet, Strategy Head, Sanofi

Michael Richardson, VP International and QPPV EU GPV&E, Bristol Myers Squibb

Eva Bredberg, Director Global Clinical Pharmacology, AstraZeneca

Anthea Tinker, Professor of Social Gerontology, Kings College London

Visit our website here: http://www.smi-online.co.uk/geriatricsummit13.asp

Alternatively, contact: Jonathan Collins on +44 (0)20 7827 6734 or email: jcollins@smi-online.co.uk

Academic & Group discounts available



Further information
Scientific News
Liquid Biopsies: Utilization of Circulating Biomarkers for Minimally Invasive Diagnostics Development
Market Trends in Biofluid-based Liquid Biopsies: Deploying Circulating Biomarkers in the Clinic. Enal Razvi, Ph.D., Managing Director, Select Biosciences, Inc.
Self-Assembling, Biomimetic Membranes May Aid Water Filtration
A synthetic membrane that self assembles and is easily produced may lead to better gas separation, water purification, drug delivery and DNA recognition, according to an international team of researchers.
Researchers Discover Immune System’s 'Trojan Horse'
Oxford University researchers have found that human cells use viruses as Trojan horses, transporting a messenger that encourages the immune system to fight the very virus that carries it.
Crystal Clear Images Uncover Secrets of Hormone Receptors
NIH researchers gain better understanding of how neuropeptide hormones trigger chemical reactions in cells.
How Cholesterol Leads to Clogged Arteries
A new study shows that when immune cells called neutrophils are exposed to cholesterol crystals, they release large extracellular web-like structures that trigger the production of inflammatory molecules linked to artherosclerosis.
Genetic Tug of War
Researchers have reported on a version of genetic parental control in mice that is more targeted, and subtle than canonical imprinting.
Ultrafast DNA Diagnostics
New technology developed by UC Berkeley bioengineers promises to make a workhorse lab tool cheaper, more portable and many times faster by accelerating the heating and cooling of genetic samples with the switch of a light.
Researchers Discover New Type of Mycovirus
Virus infects the fungus Aspergillus fumigatus, which can cause the human disease aspergillosis.
Error Correction Mechanism in Cell Division
Cell biologists have reported an advance in understanding the workings of an error correction mechanism that helps cells detect and correct mistakes in cell division early enough to prevent chromosome mis-segregation and aneuploidy, that is, having too many or too few chromosomes.
How to Become a Follicular T Helper Cell
Uncovering the signals that govern the fate of T helper cells is a big step toward improved vaccine design.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!